Rosemary A. Crane

Filings by Rosemary A. Crane span 4 companies, the busiest being Teva Pharmaceutical Industries Ltd, Certara, Inc. and Catalent, Inc. Between 5 June 2021 and 5 June 2026, the trades on record add up to 16 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The record was last updated on 8 June 2026 with an option exercise in Teva Pharmaceutical Industries Ltd. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.